Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes  Bernt Johan von Scholten, Tine Willum Hansen, Jens Peter Goetze, Frederik Persson, Peter Rossing  Journal of Diabetes and Its Complications  Volume 29, Issue 5, Pages 670-674 (July 2015) DOI: 10.1016/j.jdiacomp.2015.04.004 Copyright © 2015 Elsevier Inc. Terms and Conditions

Fig. 1 GFR results. The effect of long-term (one year) liraglutide treatment on accurately measured kidney function (51Cr-EDTA GFR). Black line represents all patients treated with liraglutide for seven weeks (day 49) and with a subsequent 3-week washout period (n=31). Blue line represents the patients who restarted liraglutide treatment after the initial study and continued treatment for one year (n=23). Green line represents patients who remained untreated after the washout period (n=7). ⁎Represents a significant change (p<0.05) from baseline. Journal of Diabetes and Its Complications 2015 29, 670-674DOI: (10.1016/j.jdiacomp.2015.04.004) Copyright © 2015 Elsevier Inc. Terms and Conditions